Prognostic Significance of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Breast Cancer
Author Information
Author(s): A Knoop, PA Andreasen, JA Andersen, S Hansen, A-V Laenkholm, ACW Simonsen, J Andersen, J Overgaard, C Rose
Primary Institution: Odense University Hospital
Hypothesis
The study investigates the relationship between uPA and PAI-1 levels in breast cancer and their correlation with prognosis.
Conclusion
High levels of PAI-1 are associated with an increased risk of distant metastasis in breast cancer patients.
Supporting Evidence
- Patients with high levels of uPA or PAI-1 had an increased risk of relapse and death.
- PAI-1 was found to independently predict distant metastasis.
- Neither uPA nor PAI-1 provided information regarding local recurrence.
Takeaway
This study found that higher levels of certain proteins in breast cancer tumors can help predict if a patient might have a relapse or die from the disease.
Methodology
The study analyzed tumor extracts from 429 breast cancer patients using an enzyme-linked immunosorbent assay to measure uPA and PAI-1 levels.
Limitations
The study is retrospective and may not account for all confounding factors.
Participant Demographics
The study included 429 primary breast cancer patients with a median follow-up of 5.1 years.
Statistical Information
P-Value
p<0.0001
Confidence Interval
1.22-2.46
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website